68 related articles for article (PubMed ID: 27485852)
1. Assessment of response rates and yields for Two opportunistic Tools for Early detection of Non-diabetic hyperglycaemia and Diabetes (ATTEND). A randomised controlled trial and cost-effectiveness analysis.
Khunti K; Gillies CL; Dallosso H; Brady EM; Gray LJ; Kilgallen G; Willis A; Zafar A; Davies MJ
Diabetes Res Clin Pract; 2016 Aug; 118():12-20. PubMed ID: 27485852
[TBL] [Abstract][Full Text] [Related]
2. The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting.
Gray LJ; Taub NA; Khunti K; Gardiner E; Hiles S; Webb DR; Srinivasan BT; Davies MJ
Diabet Med; 2010 Aug; 27(8):887-95. PubMed ID: 20653746
[TBL] [Abstract][Full Text] [Related]
3. The cost of screening for diabetes and intermediate hyperglycaemia.
Colagiuri S
Diabetes Res Clin Pract; 2012 Sep; 97(3):341-2. PubMed ID: 22682947
[No Abstract] [Full Text] [Related]
4. Progression from optimal blood glucose and pre-diabetes to type 2 diabetes in a high risk population with or without hypertension in Isfahan, Iran.
Janghorbani M; Amini M
Diabetes Res Clin Pract; 2015 Jun; 108(3):414-22. PubMed ID: 25814432
[TBL] [Abstract][Full Text] [Related]
5. [Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas].
Wierusz-Wysocka B; Zozulińska D; Knast B; Pisarczyk-Wiza D
Pol Arch Med Wewn; 2001 Sep; 106(3):815-21. PubMed ID: 11928591
[TBL] [Abstract][Full Text] [Related]
6. Identification of impaired fasting glucose, healthcare utilization and progression to diabetes in the UK using the Clinical Practice Research Datalink (CPRD).
Hong JL; McNeill AM; He J; Chen Y; Brodovicz KG
Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1375-1386. PubMed ID: 27193175
[TBL] [Abstract][Full Text] [Related]
7. One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose.
Fiorentino TV; Marini MA; Andreozzi F; Arturi F; Succurro E; Perticone M; Sciacqua A; Hribal ML; Perticone F; Sesti G
J Clin Endocrinol Metab; 2015 Oct; 100(10):3744-51. PubMed ID: 26274345
[TBL] [Abstract][Full Text] [Related]
8. A simple pragmatic system for detecting new cases of type 2 diabetes and impaired fasting glycaemia in primary care.
Greaves CJ; Stead JW; Hattersley AT; Ewings P; Brown P; Evans PH
Fam Pract; 2004 Feb; 21(1):57-62. PubMed ID: 14760046
[TBL] [Abstract][Full Text] [Related]
9. Screening for type 2 diabetes mellitus: a systematic review for the U.S. Preventive Services Task Force.
Selph S; Dana T; Blazina I; Bougatsos C; Patel H; Chou R
Ann Intern Med; 2015 Jun; 162(11):765-76. PubMed ID: 25867111
[TBL] [Abstract][Full Text] [Related]
10. Use of dental practices for the identification of adults with undiagnosed type 2 diabetes mellitus or non-diabetic hyperglycaemia: a systematic review.
Yonel Z; Cerullo E; Kröger AT; Gray LJ
Diabet Med; 2020 Sep; 37(9):1443-1453. PubMed ID: 32426909
[TBL] [Abstract][Full Text] [Related]
11. Criteria for previously undiagnosed diabetes and risk of mortality: 15-year follow-up of the Edinburgh Artery Study cohort.
Wild SH; Smith FB; Lee AJ; Fowkes FG
Diabet Med; 2005 Apr; 22(4):490-6. PubMed ID: 15787678
[TBL] [Abstract][Full Text] [Related]
12. Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients.
Madhu SV; Muduli SK; Avasthi R
Diabetes Technol Ther; 2013 Jun; 15(6):461-5. PubMed ID: 23631606
[TBL] [Abstract][Full Text] [Related]
13. A comparison of cost per case detected of screening strategies for Type 2 diabetes and impaired glucose regulation: modelling study.
Khunti K; Gillies CL; Taub NA; Mostafa SA; Hiles SL; Abrams KR; Davies MJ
Diabetes Res Clin Pract; 2012 Sep; 97(3):505-13. PubMed ID: 22554999
[TBL] [Abstract][Full Text] [Related]
14. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
[TBL] [Abstract][Full Text] [Related]
15. Role of various indices derived from an oral glucose tolerance test in the prediction of conversion from prediabetes to type 2 diabetes.
Kim YA; Ku EJ; Khang AR; Hong ES; Kim KM; Moon JH; Choi SH; Park KS; Jang HC; Lim S
Diabetes Res Clin Pract; 2014 Nov; 106(2):351-9. PubMed ID: 25245975
[TBL] [Abstract][Full Text] [Related]
16. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
17. Frequency of 1-h post-load glucose ≥155 mg/dl among individuals with different glucose tolerance conditions.
Fiorentino TV; Sesti F; Andreozzi F; Pedace E; Succurro E; Sciacqua A; Perticone F; Sesti G
Nutr Metab Cardiovasc Dis; 2016 May; 26(5):439-41. PubMed ID: 27039961
[No Abstract] [Full Text] [Related]
18. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study.
Celik C; Tasdemir N; Abali R; Bastu E; Yilmaz M
Fertil Steril; 2014 Apr; 101(4):1123-8.e1. PubMed ID: 24502891
[TBL] [Abstract][Full Text] [Related]
19. [Role of insulin resistance and β cell function in the development of newly diagnosed type 2 diabetes].
Chen X; Su M; Wang C; Wu Z; Li S; Ying X; Wei G; Fu C; Jiang Q
Wei Sheng Yan Jiu; 2015 Nov; 44(6):881-6. PubMed ID: 26738376
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of glucose abnormalities and diagnostic value of fasting glucose and fasting insulin in urban Hispanics.
Hoffmann IS; Alfieri AB; Cubeddu LX
Am J Ther; 2013; 20(4):369-75. PubMed ID: 23528370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
